135 related articles for article (PubMed ID: 38712445)
1. Elastin-derived peptides favor type 2 innate lymphoid cells in chronic obstructive pulmonary disease.
Lahire S; Fichel C; Rubaszewski O; Lerévérend C; Audonnet S; Visneux V; Perotin JM; Deslée G; Le Jan S; Potteaux S; Le Naour R; Pommier A
Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L812-L820. PubMed ID: 38712445
[TBL] [Abstract][Full Text] [Related]
2. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease.
Rinaldi M; Lehouck A; Heulens N; Lavend'homme R; Carlier V; Saint-Remy JM; Decramer M; Gayan-Ramirez G; Janssens W
Thorax; 2012 Aug; 67(8):694-700. PubMed ID: 22442201
[TBL] [Abstract][Full Text] [Related]
3. Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease.
Blomme EE; Provoost S; De Smet EG; De Grove KC; Van Eeckhoutte HP; De Volder J; Hansbro PM; Bonato M; Saetta M; Wijnant SR; Verhamme F; Joos GF; Bracke KR; Brusselle GG; Maes T
Clin Transl Immunology; 2021; 10(6):e1287. PubMed ID: 34136217
[TBL] [Abstract][Full Text] [Related]
4. The elastin peptide VGVAPG increases CD4
Lemaire F; Audonnet S; Perotin JM; Gaudry P; Dury S; Ancel J; Lebargy F; Antonicelli F; Deslée G; Le Naour R
Respir Res; 2021 Jan; 22(1):14. PubMed ID: 33435988
[TBL] [Abstract][Full Text] [Related]
5. The Role of Innate Lymphoid Cells in Chronic Respiratory Diseases.
Hsu AT; Gottschalk TA; Tsantikos E; Hibbs ML
Front Immunol; 2021; 12():733324. PubMed ID: 34630416
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease.
Borger JG; Lau M; Hibbs ML
Front Immunol; 2019; 10():1597. PubMed ID: 31354734
[TBL] [Abstract][Full Text] [Related]
7. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.
Poposki JA; Klingler AI; Tan BK; Soroosh P; Banie H; Lewis G; Hulse KE; Stevens WW; Peters AT; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Raviv JR; Karras JG; Akbari O; Kern RC; Kato A
Immun Inflamm Dis; 2017 Sep; 5(3):233-243. PubMed ID: 28474861
[TBL] [Abstract][Full Text] [Related]
8. Age-Related Dynamics of Circulating Innate Lymphoid Cells in an African Population.
Darboe A; Nielsen CM; Wolf AS; Wildfire J; Danso E; Sonko B; Bottomley C; Moore SE; Riley EM; Goodier MR
Front Immunol; 2020; 11():594107. PubMed ID: 33343571
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-α.
Eurlings IM; Dentener MA; Mercken EM; de Cabo R; Bracke KR; Vernooy JH; Wouters EF; Reynaert NL
Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(7):L557-65. PubMed ID: 25106431
[TBL] [Abstract][Full Text] [Related]
10. Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease.
Gadgil A; Duncan SR
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):531-41. PubMed ID: 19281072
[TBL] [Abstract][Full Text] [Related]
11. Role of Innate Lymphoid Cells in Lung Disease.
Marashian SM; Mortaz E; Jamaati HR; Alavi-Moghaddam M; Kiani A; Abedini A; Garssen J; Adcock IM; Velayati AA
Iran J Allergy Asthma Immunol; 2015 Aug; 14(4):346-60. PubMed ID: 26547702
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA-seq identifies a PD-1
Yu Y; Tsang JC; Wang C; Clare S; Wang J; Chen X; Brandt C; Kane L; Campos LS; Lu L; Belz GT; McKenzie AN; Teichmann SA; Dougan G; Liu P
Nature; 2016 Nov; 539(7627):102-106. PubMed ID: 27749818
[TBL] [Abstract][Full Text] [Related]
13. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.
Silver JS; Kearley J; Copenhaver AM; Sanden C; Mori M; Yu L; Pritchard GH; Berlin AA; Hunter CA; Bowler R; Erjefalt JS; Kolbeck R; Humbles AA
Nat Immunol; 2016 Jun; 17(6):626-35. PubMed ID: 27111143
[TBL] [Abstract][Full Text] [Related]
15. How Do Innate Immune Cells Contribute to Airway Remodeling in COPD Progression?
Bu T; Wang LF; Yin YQ
Int J Chron Obstruct Pulmon Dis; 2020; 15():107-116. PubMed ID: 32021149
[TBL] [Abstract][Full Text] [Related]
16. IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
Roos AB; Sandén C; Mori M; Bjermer L; Stampfli MR; Erjefält JS
Am J Respir Crit Care Med; 2015 Jun; 191(11):1232-41. PubMed ID: 25844618
[TBL] [Abstract][Full Text] [Related]
17. Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction.
Monticelli LA; Diamond JM; Saenz SA; Tait Wojno ED; Porteous MK; Cantu E; Artis D; Christie JD
Am J Respir Crit Care Med; 2020 Jan; 201(1):63-72. PubMed ID: 31394048
[No Abstract] [Full Text] [Related]
18. Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
Mizuno S; Mikami Y; Kamada N; Handa T; Hayashi A; Sato T; Matsuoka K; Matano M; Ohta Y; Sugita A; Koganei K; Sahara R; Takazoe M; Hisamatsu T; Kanai T
Inflamm Bowel Dis; 2014 Aug; 20(8):1426-34. PubMed ID: 24991784
[TBL] [Abstract][Full Text] [Related]
19. IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis.
Starkey MR; Plank MW; Casolari P; Papi A; Pavlidis S; Guo Y; Cameron GJM; Haw TJ; Tam A; Obiedat M; Donovan C; Hansbro NG; Nguyen DH; Nair PM; Kim RY; Horvat JC; Kaiko GE; Durum SK; Wark PA; Sin DD; Caramori G; Adcock IM; Foster PS; Hansbro PM
Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31196943
[TBL] [Abstract][Full Text] [Related]
20. Type 2 Diabetes Mellitus and Latent Tuberculosis Infection Moderately Influence Innate Lymphoid Cell Immune Responses in Uganda.
Ssekamatte P; Nakibuule M; Nabatanzi R; Egesa M; Musubika C; Bbuye M; Hepworth MR; Doherty DG; Cose S; Biraro IA
Front Immunol; 2021; 12():716819. PubMed ID: 34512639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
